Core Viewpoint - The company, Yipai Sunshine (02522), has announced a placement agreement to issue 35 million shares at a price of HKD 16.76 per share, representing approximately 11.93% of the enlarged issued H shares as of the announcement date [1] Summary by Categories Placement Details - The placement price of HKD 16.76 per share reflects a discount of about 12.53% compared to the closing price of HKD 19.16 on August 21, 2025 [1] - The expected net proceeds from the placement, after deducting commissions and related costs, will be approximately HKD 562 million [1] Use of Proceeds - Approximately 40% of the net proceeds will be allocated to the development of data and artificial intelligence, focusing on medical imaging data mining, annotation, and cleaning services, as well as the development of AI application platforms [1] - About 30% of the net proceeds will be used for the expansion of the company's medical imaging center business and enabling solutions through self-investment or acquisitions, targeting both domestic and overseas markets such as Hong Kong and Singapore [1] - Approximately 20% of the net proceeds will be invested in or used to establish an industrial incubation fund to invest in quality healthcare companies and third parties that align with the group's business resources [1] - The remaining 10% of the net proceeds will be allocated for general working capital [1]
一脉阳光(02522)拟折让约12.53%配售3500万股配售股份 净筹约5.62亿港元